Paragon Labs expands leadership with former Apogee executives
Paragon Labs announced that former senior leaders from Apogee Therapeutics have joined its team, led by Michael Henderson, M.D., to support clinical development of Paragon-discovered assets. The move follows Apogee's 2026 acquisition by AbbVie for over $10.9 billion.
Primary source
Company press release (PR Newswire), October 13, 2026
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
Machine-summarized from the source above; not independently reported. How we use automation